Huda Y. Zoghbi, a director at Regeneron Pharmaceuticals, sold 7,439 shares for more than $7.2 million.

REGN · Regeneron Pharmaceuticals

The AI's read

A director's sale alone says little about how Regeneron's medicines are selling or how its business is doing. The report gives no reason for the sale and describes no change to company results or plans, so this story does not change how the business is viewed.